Global Fractional Flow Reserve Market| New Market Research Report| Technavio
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180603005141/en/
Technavio has published a new market research report on the global fractional flow reserve market from 2018-2022. (Graphic: Business Wire)
The report will follow up on Technavio’s previous research on the global fractional flow reserve market, offering an up-to-date analysis of the market concerning the current market scenario, latest trends and drivers, and the overall global environment. The report also provides new predictions for the forecast period based on an in-depth analysis of the market.
The upgraded research report on the global fractional flow reserve market 2018-2022 is an integral part of Technavio’s medical imaging portfolio. Technavio covers an extensive range of market research reports on the medical imaging market, covering different regions and top industry segments. Some of the topics include stem cell therapy, endoscopy devices, blood pressure transducers, digital X-Ray systems, and hypodermic needles.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Global fractional flow reserve market: Growth opportunities
Technavio’s previous report on the global fractional flow reserve market projected that the Americas showed the highest potential in 2016 when compared to APAC and EMEA. In the Americas, factors such as the increase in the need for CAD and the launch of new cost-effective products in the market were the key factors driving growth.
A senior research analyst at Technavio stated, “One of the major drivers for market growth is the increasing need for the diagnosis of coronary artery disease. The primary reason for the increase in demand for new diagnosis techniques like the fractional flow reserve can be attributed to the limited applications of standard coronary angiography. Even though coronary angiogram is the standard procedure for the diagnosis of CAD, a clear picture of the severity of the disease can never be achieved. Furthermore, its inaccuracy in predicting the exact lesion causing ischemia will fuel market growth.”
Technavio’s new report on the global fractional flow reserve market will evaluate the key geographical regions and their behavior over the past four years, introducing new data and observations and providing new predictions. The report is available to order now and will be delivered within one week of purchase.
Global fractional flow reserve market: Detailed analysis at your fingertips
Some of the topics that will be revisited in the new report include:
- Market size and growth rate through 2022
- Top factors driving the market growth
- Market share analysis of the key players
- Market opportunities and factors impeding growth
Looking for the latest information on the global fractional flow reserve market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200